Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
ALGN's Cash to Debt is ranked higher than
91% of the 472 Companies
in the Global Medical Devices industry.

( Industry Median: 2.06 vs. ALGN: No Debt )
ALGN' s 10-Year Cash to Debt Range
Min: 5.57   Max: No Debt
Current: No Debt

Equity to Asset 0.76
ALGN's Equity to Asset is ranked higher than
81% of the 443 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. ALGN: 0.76 )
ALGN' s 10-Year Equity to Asset Range
Min: 0.55   Max: 0.89
Current: 0.76

0.55
0.89
Interest Coverage No Debt
ALGN's Interest Coverage is ranked higher than
81% of the 257 Companies
in the Global Medical Devices industry.

( Industry Median: 234.31 vs. ALGN: No Debt )
ALGN' s 10-Year Interest Coverage Range
Min: 22.24   Max: 9999.99
Current: No Debt

22.24
9999.99
F-Score: 8
Z-Score: 14.42
M-Score: -2.65
WACC vs ROIC
11.28%
51.60%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 26.30
ALGN's Operating margin (%) is ranked higher than
97% of the 456 Companies
in the Global Medical Devices industry.

( Industry Median: 5.53 vs. ALGN: 26.30 )
ALGN' s 10-Year Operating margin (%) Range
Min: -3577.86   Max: 26.54
Current: 26.3

-3577.86
26.54
Net-margin (%) 20.06
ALGN's Net-margin (%) is ranked higher than
96% of the 456 Companies
in the Global Medical Devices industry.

( Industry Median: 4.05 vs. ALGN: 20.06 )
ALGN' s 10-Year Net-margin (%) Range
Min: -3750.61   Max: 26.31
Current: 20.06

-3750.61
26.31
ROE (%) 22.50
ALGN's ROE (%) is ranked higher than
96% of the 440 Companies
in the Global Medical Devices industry.

( Industry Median: 5.22 vs. ALGN: 22.50 )
ALGN' s 10-Year ROE (%) Range
Min: -1345.04   Max: 42.13
Current: 22.5

-1345.04
42.13
ROA (%) 17.25
ALGN's ROA (%) is ranked higher than
97% of the 472 Companies
in the Global Medical Devices industry.

( Industry Median: 2.73 vs. ALGN: 17.25 )
ALGN' s 10-Year ROA (%) Range
Min: -202.5   Max: 31.86
Current: 17.25

-202.5
31.86
ROC (Joel Greenblatt) (%) 234.44
ALGN's ROC (Joel Greenblatt) (%) is ranked higher than
100% of the 470 Companies
in the Global Medical Devices industry.

( Industry Median: 9.36 vs. ALGN: 234.44 )
ALGN' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -593.01   Max: 369.18
Current: 234.44

-593.01
369.18
Revenue Growth (3Y)(%) 17.20
ALGN's Revenue Growth (3Y)(%) is ranked higher than
92% of the 333 Companies
in the Global Medical Devices industry.

( Industry Median: 5.40 vs. ALGN: 17.20 )
ALGN' s 10-Year Revenue Growth (3Y)(%) Range
Min: 7.6   Max: 144.4
Current: 17.2

7.6
144.4
EBITDA Growth (3Y)(%) -3.70
ALGN's EBITDA Growth (3Y)(%) is ranked higher than
72% of the 305 Companies
in the Global Medical Devices industry.

( Industry Median: 0.60 vs. ALGN: -3.70 )
ALGN' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -35.2   Max: 44.9
Current: -3.7

-35.2
44.9
EPS Growth (3Y)(%) -6.40
ALGN's EPS Growth (3Y)(%) is ranked higher than
71% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. ALGN: -6.40 )
ALGN' s 10-Year EPS Growth (3Y)(%) Range
Min: -76.1   Max: 289.3
Current: -6.4

-76.1
289.3
» ALGN's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

ALGN Guru Trades in Q1 2014

Joel Greenblatt 200,447 sh (New)
Steven Cohen 356,898 sh (+5545.33%)
Pioneer Investments 169,447 sh (+46.91%)
Jim Simons 757,977 sh (+12.28%)
Ron Baron 29,800 sh (unchged)
Mario Gabelli 13,500 sh (-3.57%)
Paul Tudor Jones 5,000 sh (-79.04%)
» More
Q2 2014

ALGN Guru Trades in Q2 2014

Ken Fisher 21,118 sh (New)
Mariko Gordon 79,953 sh (New)
Pioneer Investments 188,427 sh (+11.2%)
Steven Cohen 436,800 sh (unchged)
Ron Baron 29,800 sh (unchged)
Paul Tudor Jones Sold Out
Mario Gabelli 12,500 sh (-7.41%)
Jim Simons 489,381 sh (-35.44%)
Joel Greenblatt 18,854 sh (-90.59%)
» More
Q3 2014

ALGN Guru Trades in Q3 2014

Paul Tudor Jones 9,098 sh (New)
Joel Greenblatt 841,070 sh (+4360.96%)
Pioneer Investments 269,165 sh (+42.85%)
Mariko Gordon 87,435 sh (+9.36%)
Ron Baron 27,500 sh (-7.72%)
Mario Gabelli 10,000 sh (-20%)
Steven Cohen 254,800 sh (-41.67%)
Ken Fisher 9,228 sh (-56.3%)
Jim Simons 158,281 sh (-67.66%)
» More
Q4 2014

ALGN Guru Trades in Q4 2014

Ken Fisher 10,528 sh (+14.09%)
» More
» Details

Insider Trades

Latest Guru Trades with ALGN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2014-09-30 Add 4360.96%0.42%$51.62 - $57.14 $ 58.678%841070
Ken Fisher 2014-09-30 Reduce -56.3%$51.62 - $57.14 $ 58.678%9228
Mariko Gordon 2014-06-30 New Buy0.18%$48.04 - $56.32 $ 58.6713%79953
Joel Greenblatt 2014-06-30 Reduce -90.59%0.14%$48.04 - $56.32 $ 58.6713%18854
Ken Fisher 2014-06-30 New Buy$48.04 - $56.32 $ 58.6713%21118
Joel Greenblatt 2014-03-31 New Buy0.16%$50.73 - $63.95 $ 58.675%200447
Mariko Gordon 2013-12-31 Sold Out 0.18%$42.52 - $58.59 $ 58.679%0
Mario Gabelli 2013-12-31 Reduce -53.33%$42.52 - $58.59 $ 58.679%14000
John Hussman 2013-06-30 Sold Out 0.73%$30.13 - $38.16 $ 58.6770%0
Ron Baron 2012-12-31 New Buy0.01%$25.39 - $38.9 $ 58.67103%29800
Mario Gabelli 2012-09-30 Reduce -31.91%$29.25 - $39.19 $ 58.6769%32000
John Hussman 2012-06-30 Reduce -39.92%0.27%$26.67 - $34.35 $ 58.6792%751000
George Soros 2012-06-30 Sold Out 0.03%$26.67 - $34.35 $ 58.6792%0
Joel Greenblatt 2012-03-31 Sold Out 0.1%$22.67 - $28.24 $ 58.67145%0
George Soros 2012-03-31 New Buy0.03%$22.67 - $28.24 $ 58.67145%75000
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 30.10
ALGN's P/E(ttm) is ranked higher than
84% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 88.80 vs. ALGN: 30.10 )
ALGN' s 10-Year P/E(ttm) Range
Min: 5.22   Max: 489.21
Current: 30.1

5.22
489.21
Forward P/E 23.31
ALGN's Forward P/E is ranked higher than
87% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. ALGN: 23.31 )
N/A
PE(NRI) 32.60
ALGN's PE(NRI) is ranked higher than
84% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 84.40 vs. ALGN: 32.60 )
ALGN' s 10-Year PE(NRI) Range
Min: 5.21   Max: 464.75
Current: 32.6

5.21
464.75
P/B 6.00
ALGN's P/B is ranked higher than
61% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 4.18 vs. ALGN: 6.00 )
ALGN' s 10-Year P/B Range
Min: 1.86   Max: 19.02
Current: 6

1.86
19.02
P/S 6.00
ALGN's P/S is ranked higher than
62% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 3.61 vs. ALGN: 6.00 )
ALGN' s 10-Year P/S Range
Min: 1.31   Max: 9.43
Current: 6

1.31
9.43
PFCF 22.20
ALGN's PFCF is ranked higher than
91% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. ALGN: 22.20 )
ALGN' s 10-Year PFCF Range
Min: 11.21   Max: 2846
Current: 22.2

11.21
2846
POCF 21.73
ALGN's POCF is ranked higher than
82% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 58.93 vs. ALGN: 21.73 )
ALGN' s 10-Year POCF Range
Min: 8.39   Max: 338.5
Current: 21.73

8.39
338.5
EV-to-EBIT 21.92
ALGN's EV-to-EBIT is ranked higher than
85% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 74.50 vs. ALGN: 21.92 )
ALGN' s 10-Year EV-to-EBIT Range
Min: -215.4   Max: 287.7
Current: 21.92

-215.4
287.7
Shiller P/E 57.90
ALGN's Shiller P/E is ranked higher than
86% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. ALGN: 57.90 )
ALGN' s 10-Year Shiller P/E Range
Min: 30.52   Max: 136.15
Current: 57.9

30.52
136.15
Current Ratio 3.10
ALGN's Current Ratio is ranked higher than
74% of the 464 Companies
in the Global Medical Devices industry.

( Industry Median: 2.59 vs. ALGN: 3.10 )
ALGN' s 10-Year Current Ratio Range
Min: 1.59   Max: 6.96
Current: 3.1

1.59
6.96
Quick Ratio 3.02
ALGN's Quick Ratio is ranked higher than
80% of the 464 Companies
in the Global Medical Devices industry.

( Industry Median: 1.96 vs. ALGN: 3.02 )
ALGN' s 10-Year Quick Ratio Range
Min: 1.55   Max: 6.82
Current: 3.02

1.55
6.82
Days Inventory 30.33
ALGN's Days Inventory is ranked higher than
97% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 160.07 vs. ALGN: 30.33 )
ALGN' s 10-Year Days Inventory Range
Min: 9.28   Max: 32.75
Current: 30.33

9.28
32.75
Days Sales Outstanding 64.03
ALGN's Days Sales Outstanding is ranked higher than
79% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 79.24 vs. ALGN: 64.03 )
ALGN' s 10-Year Days Sales Outstanding Range
Min: 51.64   Max: 278.86
Current: 64.03

51.64
278.86

Valuation & Return

vs
industry
vs
history
Price/Net Cash 23.66
ALGN's Price/Net Cash is ranked higher than
87% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. ALGN: 23.66 )
ALGN' s 10-Year Price/Net Cash Range
Min: 2.22   Max: 417
Current: 23.66

2.22
417
Price/Net Current Asset Value 15.48
ALGN's Price/Net Current Asset Value is ranked higher than
83% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. ALGN: 15.48 )
ALGN' s 10-Year Price/Net Current Asset Value Range
Min: 1.96   Max: 52.5
Current: 15.48

1.96
52.5
Price/Tangible Book 7.39
ALGN's Price/Tangible Book is ranked higher than
69% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 7.44 vs. ALGN: 7.39 )
ALGN' s 10-Year Price/Tangible Book Range
Min: 1.17   Max: 16.39
Current: 7.39

1.17
16.39
Price/DCF (Projected) 2.27
ALGN's Price/DCF (Projected) is ranked higher than
87% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. ALGN: 2.27 )
ALGN' s 10-Year Price/DCF (Projected) Range
Min: 1.38   Max: 14.76
Current: 2.27

1.38
14.76
Price/Median PS Value 1.60
ALGN's Price/Median PS Value is ranked higher than
63% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 1.25 vs. ALGN: 1.60 )
ALGN' s 10-Year Price/Median PS Value Range
Min: 0.43   Max: 8.11
Current: 1.6

0.43
8.11
Price/Graham Number 3.22
ALGN's Price/Graham Number is ranked higher than
83% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. ALGN: 3.22 )
ALGN' s 10-Year Price/Graham Number Range
Min: 0.85   Max: 17.12
Current: 3.22

0.85
17.12
Earnings Yield (Greenblatt) 5.00
ALGN's Earnings Yield (Greenblatt) is ranked higher than
85% of the 467 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. ALGN: 5.00 )
ALGN' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.3   Max: 9.7
Current: 5

0.3
9.7

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:AFW.Germany,
Align Technology Inc was founded in March 1997 and incorporated in Delaware in April 1997. The Company designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM (computer-aided design and computer-aided manufacturing) digital services used in dentistry, orthodontics, and dental records storage. The Company has two operating segments: Clear Aligner segment and SCCS segment. Its Clear Aligner segment consists of its Invisalign System which includes Invisalign Full, Express/Lite, Teen, Assist, Vivera Retainers, along with its training and ancillary products for treating malocclusion. The SCCS segment consists of intra-oral scanning systems, and additional services available with the intra-oral scanners, that provide digital alternatives to the traditional cast models. This segment includes its iTero scanner and OrthoCAD services. The Company distributes its products directly to its customers: orthodontists and general practitioner dentists as well as to restorative dentists, including prosthodontists, periodontists, and oral surgeons. The Companys manufacturing facilities are located in Juarez, Mexico, where it conduct its aligner fabrication, distribute and repair its scanners, perform its CAD/CAM services, and in Or Yehuda, Israel where it produce its handheld intra-oral scanner wand. As of December 31, 2013, the Company had 313 issued U.S. patents, 124 pending U.S. patent applications, and 239 foreign issued patents, as well as 116 pending foreign patent applications. Its trademarks include Invisalign, Align, ClinCheck, Invisalign Assist, Invisalign Teen, Vivera, SmartForce, SmartTrack, Power Ridge and iTero. The Company competes with Danaher Corporation, 3M, Sirona Dental Systems, Inc., Dentsply International, Inc. and among others. The Company is subject to various laws inside and outside the U.S. concerning its relationships with healthcare professionals and government officials, price reporting and regulation, the promotion, sales and marketing of its products and services, the importation and exportation of its products, the operation of its facilities and distribution of its products. It is also subject to varying degrees of government regulation in the various countries in which the Company do business.
» More Articles for ALGN

Headlines

Articles On GuruFocus.com
Align Technology to Present at Upcoming J.P. Morgan Healthcare Conference Jan 08 2015 
Align Technology to Announce Fourth Quarter and Fiscal Year 2014 Results on January 29, 2015 Jan 02 2015 
Align Technology Launches Chairside CAD/CAM Workflow With IOS Technologies for the iTero Scanner Nov 28 2014 
Align Technology to Present at Upcoming Financial Conferences Nov 25 2014 
Align Technology Continues Research Award Program for 2015 Nov 03 2014 
Align Technology to Present at Upcoming Financial Conferences Oct 29 2014 
Align Technology to Announce Third Quarter 2014 Results on October 23, 2014 Oct 15 2014 
Valeant Pharmaceuticals Part X: a follow up on the sale of facial injectables Aug 11 2014 
WEEKLY CFO SELLS HIGHLIGHT: CY, UTEK, STJ, ALGN, TXN, JAH, YUM May 01 2011 
Align Technologies Takes One in the Teeth Apr 06 2010 

More From Other Websites
Mid-Morning Market Update: Markets Drop; Mastercard Profit Tops Expectations Jan 30 2015
Align Technology (ALGN) Stock Drops Today Following Earnings Release Jan 30 2015
Align Technology misses 4Q profit forecasts Jan 29 2015
Align Technology misses 4Q profit forecasts Jan 29 2015
Align Technology Inc Earnings Call scheduled for 4:30 pm ET today Jan 29 2015
Align Technology Announces Fourth Quarter and 2014 Results Jan 29 2015
ALIGN TECHNOLOGY INC Files SEC form 8-K, Results of Operations and Financial Condition Jan 29 2015
4:02 pm Align Tech misses by $0.01, reports revs in-line; guides Q1 EPS below consensus, revs below... Jan 29 2015
Align Technology Announces Fourth Quarter and 2014 Results Jan 29 2015
Q4 2014 Align Technology Inc Earnings Release - After Market Close Jan 29 2015
Will Abiomed (ABMD) Outshine Q3 Earnings Estimates? - Analyst Blog Jan 23 2015
Can Covidien (COV) Keep Its Earnings Streak Alive? - Analyst Blog Jan 20 2015
Stocks End Five-Day Slide; HDFC Bank Rises Jan 16 2015
Stocks On Pace To End Slide; Tessera Up Sharply Jan 16 2015
Align Technology to Present at Upcoming J.P. Morgan Healthcare Conference Jan 08 2015
Align Technology to Announce Fourth Quarter and Fiscal Year 2014 Results on January 29, 2015 Jan 02 2015
Align Technology to Announce Fourth Quarter and Fiscal Year 2014 Results on January 29, 2015 Jan 02 2015
Analysts' Actions: Align, Bed, Bath & Beyond, Noble Energy and More Jan 02 2015
Align Tech upgraded by Robert W. Baird Jan 02 2015
Cramer: This boring industry is red hot Dec 22 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK